Cannabis Clinical Trials

TEL AVIV, Israel, October 18, 2017 /PRNewswire/ — Therapix Biosciences Ltd. (Nasdaq: TRPX) (“Therapix” or the “Company”), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, signed an agreement with Assuta Medical Center, the largest hospital network and private healthcare provider in Israel, to conduct a Phase IIa, sponsor-initiated trial (the “OSA […]

by

There are road races where you’re encouraged to run high, and gyms dedicated to working out stoned. But what actually happens if you smoke weed and then run—or jump, or lift? “How marijuana affects your workout or performance depends largely on the type of exercise and goal at hand,” says Jordan Tishler, M.D., a Harvard-trained […]

by

TEL AVIV, Israel, October 18, 2017 /PRNewswire/ — Therapix Biosciences Ltd. (Nasdaq: TRPX) (“Therapix” or the “Company”), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, signed an agreement with Assuta Medical Center, the largest hospital network and private healthcare provider in Israel, to conduct a Phase IIa, sponsor-initiated trial (the “OSA […]

by

OTTAWA, ONTARIO–(Marketwired – Oct. 18, 2017) – Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, today announced that it will start promoting a co-developed medical cannabis blend product under Access to Cannabis for Medical Purposes Regulations (ACMPR). Tetra has signed a distribution agreement with its […]

by

International Cannabis and Cannabinoids Institute (ICCI) welcomes Ethan Russo, MD as the new Director of Research and Development. ICCI is the first-ever international Center of Excellence for the advancement of cannabis and cannabinoid treatments located in the Czech Republic. ICCI identifies, coordinates, and supports global research priorities for the advancement of cannabis and cannabinoid treatments […]

by

The United Cannabis Corporation (OTCMKTS:CNAB) has been at the forefront of medical cannabis research in the United States since its legalization in major states. The company has recently received a go-ahead by the Jamaican government to produce and distribute Prana CBD-infused water in the country as medical cannabis through its subsidiary, Cannabinoid Research Development Limited […]

by

Israelis gather at the Rose Garden in front of the Knesset legislature to smoke marijuana on April 20, 2016. Photo: Hadas Parush / Flash90. After holding its third innovation conference in Tel Aviv in March, iCAN: Israel-Cannabis — an Israeli marijuana group — is hosting the inaugural CannaTech UK convention on October 26 at London’s Old Truman Brewery. The Israeli organization’s stated mission is […]

by

According to a forecast report by Arcview Market Research, growth in the legal cannabis market will re-accelerate in the beginning of 2018, as adult use (recreational use) sales are expected to ramp up in Canada, California, and Massachusetts along with medical sales in Florida. The market is expected to grow from the $6.7 billion market […]

by

New research suggests that the cannabis-extract cannabidiol could help treat autism. Autism is challenging to treat pharmacologically because there’s no single cause. Autism can be caused by genetic factors, environmental factors (e.g., pesticide exposure) or a combination of both. Depending on the underlying cause, the severity of symptoms ranges across a spectrum, thus leading to […]

by

ONLY 11 doctors in Queensland have the authority to prescribe medicinal cannabis. The NewsMail made inquiries this week after receiving reports of difficulty in accessing medical marijuana and the story of Sunshine Coast woman Katrina Spraggon, which went viral online. Ms Spraggon’s daughter has 18 medical issues and she has been treating her with medical […]

by

The legalisation of medicinal cannabis in Australia was largely enabled by the Narcotic Drugs Amendment Act 2016 (Cth), which permits research, cultivation and production of medicinal cannabis and related products. Corresponding amendments have also been made to the Therapeutic Goods Act 1989 (Cth) to facilitate regulatory approvals and alternative access schemes for unapproved medicinal cannabis […]

by